|
|
|
Volumn 7, Issue 1, 1996, Pages 8-9
|
|
3TC approval may revive AZT's appeal.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DRUG APPROVAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
VIROLOGY;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTIVIRAL AGENTS;
CD4 LYMPHOCYTE COUNT;
DRUG APPROVAL;
HIV;
HUMANS;
LAMIVUDINE;
REVERSE TRANSCRIPTASE INHIBITORS;
ZALCITABINE;
ZIDOVUDINE;
|
|
EID: 0029680999
PISSN: 15232883
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
